CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies
Launched by LILLE CATHOLIC UNIVERSITY · Jan 4, 2021
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
The CRYSTALILLE Cohort trial is focused on understanding and improving the treatment of certain types of arthritis caused by crystal deposits in the joints, specifically gout and other related conditions. Researchers aim to gather information from patients at the Groupement des Hôpitaux de l'Institut Catholique de Lille to create a detailed picture of these diseases. This study will use medical imaging techniques to help doctors better diagnose and manage these conditions.
To participate in this trial, you should be between 65 and 74 years old and have been diagnosed with gout, calcium pyrophosphate crystal disease, or hydroxyapatite crystal rheumatism. You should also be someone who has had or will benefit from an ultrasound or special type of scan to check for crystal deposits. If you join, you can expect to undergo imaging tests and provide some health information that will help researchers learn more about these conditions. It's important to know that if you have any reservations about participating or if you're unable to undergo the necessary imaging, you may not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of gout according to American College of Rheumatology /European League Against Rheumatism (ACR/EULAR) 2015 criteria OR diagnosis of calcium pyrophosphate dihydrate crystal deposition disease (CPPD) based on EULAR 2011 recommendations OR diagnosis of hydroxyapatite crystal rheumatism (HCR) according to a typical clinical sequence and demonstration of compatible calcium deposits on imaging
- • patient who will benefit or has benefited from an ultrasound and/or DECT evaluation of microcrystalline deposits
- • clinical suspicion of microcrystalline rheumatism requiring further imaging to confirm the diagnosis
- Exclusion Criteria:
- • Refusal or contra-indication to perform ultrasound or dual energy scanning.
- • Patient's opposition to the use of his or her health data for research purposes
- • Patient under guardianship or curatorship
- • Pregnant woman
- • Person not affiliated to a social security scheme or entitled to a social security benefit
About Lille Catholic University
Lille Catholic University, a prominent academic institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates expertise from various fields to foster the development of cutting-edge medical solutions. Its commitment to ethical standards and patient-centered approaches ensures that clinical trials conducted under its auspices are rigorous, scientifically sound, and aligned with the highest standards of care. By leveraging its extensive network of researchers, healthcare professionals, and resources, Lille Catholic University plays a vital role in contributing to the enhancement of medical knowledge and the improvement of patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lomme, , France
Patients applied
Trial Officials
Tristan Pascart, MD
Principal Investigator
GHICL
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials